This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Apr;131(4):546-7.

doi: 10.1001/jamaophthalmol.2013.35.

In reply to Mireskandari and coworkers

Michael P Blair, Michael J Shapiro

PMID: 23579610
DOI: 10.1001/jamaophthalmol.2013.35

Comment

In reply to Mireskandari and coworkers

Michael P Blair et al. JAMA Ophthalmol. 2013 Apr.

. 2013 Apr;131(4):546-7.

doi: 10.1001/jamaophthalmol.2013.35.

Authors

Michael P Blair, Michael J Shapiro

PMID: 23579610
DOI: 10.1001/jamaophthalmol.2013.35

No abstract available

PubMed Disclaimer

Comment on

Reactivation of retinopathy of prematurity after bevacizumab injection.
Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R. Hu J, et al. Arch Ophthalmol. 2012 Aug;130(8):1000-6. doi: 10.1001/archophthalmol.2012.592. Arch Ophthalmol. 2012. PMID: 22491394
Recurrence of retinopathy of prematurity following bevacizumab monotherapy: is it only the tip of the iceberg?
Mireskandari K, Adams GG, Tehrani NN. Mireskandari K, et al. JAMA Ophthalmol. 2013 Apr;131(4):544-5. doi: 10.1001/jamaophthalmol.2013.711. JAMA Ophthalmol. 2013. PMID: 23579608 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations